Adherium Ltd (ADR) - Cash Flow Conversion Efficiency

Latest as of December 2025: 9.437x

Based on the latest financial reports, Adherium Ltd (ADR) has a cash flow conversion efficiency ratio of 9.437x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-7.43 Million ≈ $-5.26 Million USD) by net assets (AU$-787.24K ≈ $-557.02K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Adherium Ltd - Cash Flow Conversion Efficiency Trend (2013–2025)

This chart illustrates how Adherium Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read total liabilities of Adherium Ltd for a breakdown of total debt and financial obligations.

Adherium Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Adherium Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Labrador Gold Corp
V:LAB
-0.002x
Renoworks Software Inc
V:RW
-0.033x
LCK Global Kedaton
JK:LCKM
0.002x
Industrial Minerals Ltd
AU:IND
-0.077x
Canstar Resources Inc
V:ROX
4.248x
Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares
NASDAQ:HKPD
-0.018x
AuQ Gold Mining Inc
V:AUQ
-1.956x
Hexicon AB
ST:HEXI
0.041x

Annual Cash Flow Conversion Efficiency for Adherium Ltd (2013–2025)

The table below shows the annual cash flow conversion efficiency of Adherium Ltd from 2013 to 2025. For the full company profile with market capitalisation and key ratios, see ADR stock market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-06-30 AU$-4.76 Million
≈ $-3.37 Million
AU$-9.98 Million
≈ $-7.06 Million
2.096x +227.98%
2024-06-30 AU$6.48 Million
≈ $4.59 Million
AU$-10.61 Million
≈ $-7.51 Million
-1.638x -62.64%
2023-06-30 AU$9.21 Million
≈ $6.52 Million
AU$-9.28 Million
≈ $-6.56 Million
-1.007x +41.98%
2022-06-30 AU$5.54 Million
≈ $3.92 Million
AU$-9.61 Million
≈ $-6.80 Million
-1.736x -116.08%
2021-06-30 AU$14.04 Million
≈ $9.93 Million
AU$-11.27 Million
≈ $-7.98 Million
-0.803x +62.85%
2020-06-30 AU$3.38 Million
≈ $2.39 Million
AU$-7.32 Million
≈ $-5.18 Million
-2.162x +84.80%
2019-06-30 AU$830.00K
≈ $587.28K
AU$-11.81 Million
≈ $-8.35 Million
-14.225x -1754.91%
2018-06-30 AU$12.81 Million
≈ $9.06 Million
AU$-9.82 Million
≈ $-6.95 Million
-0.767x -50.35%
2017-06-30 AU$22.70 Million
≈ $16.07 Million
AU$-11.58 Million
≈ $-8.19 Million
-0.510x -76.99%
2016-06-30 AU$27.46 Million
≈ $19.43 Million
AU$-7.91 Million
≈ $-5.60 Million
-0.288x -43364.50%
2015-06-30 AU$34.53 Million
≈ $24.43 Million
AU$23.00K
≈ $16.27K
0.001x +100.07%
2014-06-30 AU$2.17 Million
≈ $1.53 Million
AU$-2.16 Million
≈ $-1.53 Million
-0.998x +0.00%
2014-03-31 AU$2.31 Million
≈ $1.64 Million
AU$-2.31 Million
≈ $-1.63 Million
-0.998x -24548.25%
2013-06-30 AU$3.50 Million
≈ $2.48 Million
AU$-14.19K
≈ $-10.04K
-0.004x --

About Adherium Ltd

AU:ADR Australia Medical Devices
Market Cap
$7.37 Million
AU$10.42 Million AUD
Market Cap Rank
#27548 Global
#1434 in Australia
Share Price
AU$0.00
Change (1 day)
+0.00%
52-Week Range
AU$0.00 - AU$0.01
All Time High
AU$10.31
About

Adherium Limited, a digital health company, develops, manufactures, and supplies digital health technologies that address sub-optimal medication use in chronic diseases in New Zealand, Australia, Europe, and North America. The company offers Hailie Smartinhaler, a system for management of chronic respiratory conditions, including asthma and chronic obstructive pulmonary disease. It also provides … Read more